This Series on “Adult Inherited Metabolic Disorders” is edited by Dr. Amro Maarouf from The Royal Wolverhampton NHS trust, Wolverhampton, UK and Dr. Nathan Lorde from Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Amro Maarouf, MBChB, MSc, MRCP(UK), FRCPath
Department of Clinical Chemistry, The Royal Wolverhampton NHS Trust, Black Country Pathology Services, Wolverhampton, UK
Dr Maarouf graduated from the University of Birmingham and works a specialist registrar in Chemical Pathology/Metabolic Medicine in the West Midlands. Prior to this, he was working as a general practitioner in a busy urban practice in Birmingham for several years. A gravitation towards abnormal biochemistry results in primary care, made re-training in clinical biochemistry an easy transition.
Dr Maarouf’s clinical interests include the management of lipids, diabetes, obesity and metabolic bone disorders. He is particularly interested in some of the rarer lipid diseases which may have a genetic basis.
Nathan Lorde, MBChB (Hons), MRCP(UK), FRCPath
Deaprtment of Clinical Chemsitry, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Dr Lorde is a senior post-graduate medical trainee in Chemical Pathology in the West Midlands. He studied medicine at the University of Leicester where he became interested in Chemical Pathology during a course on physiological measurement. After Foundation and Core Medical post-graduate rotations he worked for two years as a Research Fellow in Renal Medicine, attracted to his by the heavy reliance on biochemistry in daily practice. Following this fellowship he was successful in obtaining a national training position in Chemical Pathology where he has developed interests in cardiovascular risk reduction and the safe and effective use of the Clinical Chemistry Laboratory in the provision of patient care. One particular field of patient diagnostics and management which relies quite heavily on the use of information from the Clinical Chemistry Laboratory is the group of the inherited metabolic disorders.
Series Outline:
- Hypobetalipoproteinemia
- Hypoalphalipoproteinemia
- Familial chylomicronemia syndrome
- Porphyria
- Maturity-onset diabetes of the Young (MODY)
- Hyperammonemia in adults
- Homocystinuria
- A review of Fabry's disease
- Hypobetalipoproteinemia
- Hypoalphalipoproteinemia
- Familial chylomicronemia syndrome
Disclosure:
The series “Adult Inherited Metabolic Disorders” was commissioned by the editorial office, Journal of Laboratory and Precision Medicine without any sponsorship or funding. Amro Maarouf and Nathan Lorde serve as the unpaid Guest Editors for the series.